Apretude Medical Information - Our HIV Medications

Prescribing Information, including boxed warning

Patient Information

Medical Information Documents
Efficacy Data

Use of Apretude in MSM and Transgender Women

Use of Apretude in Cisgender Women

Use of Cabotegravir LA for PrEP (Infographic)

Resistance Reported in HPTN 083 and 084

Use of Apretude in Transgender Men

Use of Apretude in People Who Inject Drugs

Diagnostic Delays Associated with Apretude Use

Time to Protection

Availability of Conference Presentation Materials for HPTN 083 and HPTN 084

Dosing and Administration

Use of Apretude Without Use of the Oral Lead-In

Extended Interval dosing of Apretude

Dosing of Apretude and Oral Bridging

Guidelines

Place of Apretude in Guidelines

Implementation and Storage

Storage and Stability of Apretude

Availability of FDA-Approved Tests for the Diagnosis of Acute or Primary HIV-1 Infection

Data in Pediatrics

Use of Apretude in Children and Adolescents

Pharmacokinetics and Drug Interactions

Metabolic Considerations and DDIs with Apretude

Potential for Interactions between Apretude and Gender-Affirming Hormones

Use of Apretude in Patients with Buttock Implants, Dermal Fillers, or Autologous Fat Transfer

Distribution of Cabotegravir following IM Injection into Plasma and Mucosal Tissues and Fluids

Safety Data

Injection Site Reactions with Apretude

Effect of Cabotegravir on Serum Creatinine

Pregnancy Outcomes in Participants receiving Apretude

Changes in Bone Mineral Density when receiving Apretude

Metabolic/Cardiac Safety

Effect of Apretude on Weight

Effect of Apretude on Lipids

Patient Reported Outcomes

Choice of PrEP at Onset of OLE in HPTN 083
Recent Congress Data
On Demand Medical Videos
Congress Data

Post-CROI 2021 Webinar
Andrew Zolopa, MD, VP, Head, North America Medical Affairs
Implementation Resources

APRETUDE Implementation Guidance for Clinics

Long-Acting Agent Resource Center

Long-Acting Injectable PrEP | NASTAD

Long-Acting Injectable PrEP is Here: Frequently Asked Questions (FAQs) for Implementation | NSTAD

HPTN 083 website

HPTN 084 website

Connect With Us

Are you a US healthcare provider?

This web portal is intended as an educational resource for healthcare providers practicing in the United States. It may include information about products or uses that have not been approved by the US Food and Drug Administration.

If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse.

Yes